Home / Import refusals / SCS-1353122-4/21/1

FDA Import Refusal SCS-1353122-4/21/1 — Aesica Queenborough Limited

Aesica Queenborough Limited — FEI 3002806345

The FDA refused shipment SCS-1353122-4/21/1 from Aesica Queenborough Limited (United Kingdom) on November 9, 2018. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 9, 2018
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1200631 (VAI Fri May 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1129263 (VAI Fri May 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993653 (VAI Fri Nov 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 920017 (VAI Fri Feb 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 776664 (NAI Fri Feb 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-1353122-4/11/1 (Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-1353122-4/31/1 (Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-1119871-7/1/1 (Wed Oct 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-7331298-8/1/1 (Thu Apr 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • FP1-0008186-7/17/1 (Fri Oct 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources